GNH USA

Europe — EMA

Kortikoid-Ratiopharm

GNH USA supplies Kortikoid‑Ratiopharm (Triamcinolone Acetonide), a corticosteroid for eczema, psoriasis, atopic dermatitis and other inflammatory skin

Triamcinolone Acetonide

Request sourcing

1
Pack/s

What is Triamcinolone Acetonide?

Triamcinolone Acetonide, the active ingredient in Kortikoid‑Ratiopharm, is a glucocorticoid corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and itching in various dermatologic conditions in adults and children. It is indicated for short‑term treatment of inflammatory dermatoses and is formulated to provide rapid symptom relief while minimizing systemic absorption.

GNH USA supplies Kortikoid‑Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions.

What is Triamcinolone Acetonide used for?

Kortikoid‑Ratiopharm (triamcinolone acetonide) is applied topically to manage inflammatory skin disorders.

- Eczema: reduces redness, swelling and itching associated with the condition. - Atopic dermatitis: controls flare‑ups and improves skin barrier function. - Psoriasis: diminishes plaque formation and scaling. - Contact dermatitis: alleviates irritation caused by allergens or irritants. - Other inflammatory skin disorders: provides anti‑inflammatory relief in various dermatoses.

What are the side effects of Triamcinolone Acetonide?

Topical application of triamcinolone acetonide may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning sensation - Mild itching or dryness - Erythema at application site - Folliculitis - Transient acneiform eruption

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use - Telangiectasia formation - Hypopigmentation or depigmentation - Secondary bacterial, fungal or viral infection - Systemic glucocorticoid effects such as adrenal suppression (rare)

What precautions apply to Triamcinolone Acetonide?

When using Kortikoid‑Ratiopharm, consider the following precautions.

- Pregnancy: safety not established; use only if benefit outweighs risk. - Pediatric use: limit duration and surface area; monitor for growth effects. - Elderly: assess skin fragility and risk of atrophy. - Concurrent infection: avoid use on infected skin unless combined with antimicrobial therapy. - Systemic absorption: caution when applied over large areas or under occlusion. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

What does Triamcinolone Acetonide interact with?

Triamcinolone acetonide may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise local concentration. - Live vaccines: topical steroids may reduce local immune response.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topicals: potential additive irritation. - Occlusive dressings: enhance absorption, monitor for side effects. - Other dermatologic agents (e.g., retinoids): may increase irritation.

Frequently asked questions

What is Kortikoid‑Ratiopharm used for?+
Kortikoid‑Ratiopharm contains triamcinolone acetonide, a topical corticosteroid indicated for the treatment of inflammatory skin conditions such as eczema, atopic dermatitis, psoriasis, contact dermatitis and other similar dermatoses. It helps to reduce redness, swelling, itching and scaling associated with these disorders.
How does triamcinolone acetonide work?+
Triamcinolone acetonide penetrates the skin and binds to intracellular glucocorticoid receptors. This complex alters gene transcription, increasing anti‑inflammatory proteins while suppressing pro‑inflammatory cytokines, prostaglandins and other mediators. The result is decreased inflammation, reduced immune cell activity and relief of symptoms.
What is the usual dose of Kortikoid‑Ratiopharm?+
The appropriate dose and duration are determined by the prescribing healthcare professional based on the specific condition, severity, patient age and the area of skin to be treated. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.
Is Kortikoid‑Ratiopharm safe during pregnancy or breastfeeding?+
Safety data for triamcinolone acetonide in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Kortikoid‑Ratiopharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.
How does Kortikoid‑Ratiopharm compare with other topical corticosteroids?+
Kortikoid‑Ratiopharm (triamcinolone acetonide) is a mid‑potency glucocorticoid, offering a balance between efficacy and risk of skin atrophy compared with higher‑potency agents such as betamethasone dipropionate. It provides strong anti‑inflammatory action while generally causing fewer systemic effects when used as directed.
How should Kortikoid‑Ratiopharm be stored and handled?+
Store the product at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed when not in use and keep it out of reach of children. Do not freeze or expose to extreme heat.
How is Kortikoid‑Ratiopharm administered?+
Apply a thin layer of the cream or ointment to the affected skin area, usually 1–2 times daily, unless otherwise directed by a clinician. Wash hands before and after application, avoid contact with eyes, and do not cover the treated area with occlusive dressings unless instructed.
What are the most serious risks associated with Kortikoid‑Ratiopharm?+
Serious risks include skin atrophy or thinning, development of telangiectasia, hypopigmentation, and, rarely, systemic glucocorticoid effects such as adrenal suppression when large areas are treated or occlusion is used. Secondary infections of the skin may also occur and require medical attention.
Who should not use Kortikoid‑Ratiopharm?+
Patients with known hypersensitivity to triamcinolone acetonide or any excipients in the formulation should avoid use. It is also contraindicated on skin infected with bacterial, fungal or viral agents unless combined with appropriate antimicrobial therapy, and should be used with caution in patients with uncontrolled diabetes, severe skin atrophy or systemic steroid therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Triamcinolone Acetonide
Route
Cutaneous Use
Manufacturer
Ratiopharm Gmbh
Origin
EU

Related products